chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: chill; half face was swelling; fever (99-100F); much stronger pain with the tooth; much stronger pain with the tooth; This is a spontaneous report from a contactable consumer reported for himself. A 44-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 24Mar2021 15:45 (Batch/Lot Number: ER8727) as single dose for covid-19 immunisation. Medical history included one tooth with some inflammation and pain. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  None allergies to medications, food, or other products. The patient's concomitant medications were none. The patient experienced much stronger pain with the tooth on 24Mar2021 18:15 with outcome of recovered, half face was swelling on 25Mar2021 (next morning)with outcome of recovered, fever (99-100f) on 25Mar2021 (next morning)with outcome of unknown, chill on unspecified date with outcome of recovered. The chill, swelling and pain last 3-4 days post injection. Therapeutic measures (Advil) were taken as a result of much stronger pain with the tooth.  Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Arthritis, COVID-19, Decreased appetite, Drug ineffective
Clinical narrative: pain and inflammation in the joints of the ankles knees and her jaw; pain and inflammation in the joints of the ankles knees and her jaw; Inflammation in the jaw was making difficult to eat and chew; Inflammation in the jaw was making difficult to eat and chew; she was infected with the COVID-19 virus on January; she was infected with the COVID-19 virus on January; This is a spontaneous report from a contactable consumer.  A 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient calls for information about the side effects she experienced after the administration of the first dose of the Pfizer's COVID-19 vaccine. She was experiencing pain and inflammation in the joints of the ankles, knees and her jaw and the inflammation in the jaw was making difficult to eat and chew. She is managing this symptoms with Tylenol and she has not visited her Physician for more information and management. She was infected with the COVID-19 virus on January. She has an appointment for the administration of the second dose of the Pfizer's COVID-19 vaccine on April the 22nd. Treatment received. Outcome was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021377325 Same reporter/drug/event, different patient.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mastication disorder
Clinical narrative: pain and inflammation in the joints of the ankles knees and her jaw; pain and inflammation in the joints of the ankles knees and her jaw; Inflammation in the jaw was making difficult to eat and chew; Inflammation in the jaw was making difficult to eat and chew; she was infected with the COVID-19 virus on January; she was infected with the COVID-19 virus on January; This is a spontaneous report from a contactable consumer.  A 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient calls for information about the side effects she experienced after the administration of the first dose of the Pfizer's COVID-19 vaccine. She was experiencing pain and inflammation in the joints of the ankles, knees and her jaw and the inflammation in the jaw was making difficult to eat and chew. She is managing this symptoms with Tylenol and she has not visited her Physician for more information and management. She was infected with the COVID-19 virus on January. She has an appointment for the administration of the second dose of the Pfizer's COVID-19 vaccine on April the 22nd. Treatment received. Outcome was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021377325 Same reporter/drug/event, different patient.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Arthritis, Osteitis, Pain in jaw
Clinical narrative: pain and inflammation in the joints of the ankles knees and her jaw; pain and inflammation in the joints of the ankles knees and her jaw; Inflammation in the jaw was making difficult to eat and chew; Inflammation in the jaw was making difficult to eat and chew; she was infected with the COVID-19 virus on January; she was infected with the COVID-19 virus on January; This is a spontaneous report from a contactable consumer.  A 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient calls for information about the side effects she experienced after the administration of the first dose of the Pfizer's COVID-19 vaccine. She was experiencing pain and inflammation in the joints of the ankles, knees and her jaw and the inflammation in the jaw was making difficult to eat and chew. She is managing this symptoms with Tylenol and she has not visited her Physician for more information and management. She was infected with the COVID-19 virus on January. She has an appointment for the administration of the second dose of the Pfizer's COVID-19 vaccine on April the 22nd. Treatment received. Outcome was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021377325 Same reporter/drug/event, different patient.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: break out in a full body rash; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 23Mar2021 12:00 (Lot Number: EN6207) as SINGLE DOSE for covid-19 immunisation. The patient medical history included HIV. There were no prior vaccinations (within 4 weeks). Concomitant medication(s) included emtricitabine, tenofovir disoproxil fumarate (TRUVADA) from 2018 (reported as started 3 years ago) and ongoing taken for hiv. The patient experienced break out in a full body rash on 25Mar2021 and it was still with him. No emergency room or physician office visit. The patient was scheduled for the second dose on 19Apr2021. The outcome was not recovered.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: wound up with COVID 3 days later; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN), via an unspecified route of administration on 19Mar2021 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 22Mar2021, patient wound up with covid 3 days later the vaccination. The patient underwent lab test which included SARS-CoV-2 Test: Positive on 22Mar2021. The patient was due for her second dose on 16Apr2021 and is asking if she should continue or wait 90 days because she has been getting conflicting answers. The outcome of the event was unknown.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Ear pruritus, Fatigue, Headache, Lip swelling, Nasal discomfort
Clinical narrative: some inner ear itching; face felt itchy but looked normal; achy here and there; nose felt hot; lips swelled up; Bilateral thighs felt a pulling sensation, upper and lower; bad headache; tired; had some tongue swelling and blistering/swelling; had some tongue swelling and blistering; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Within 2 hours the patient had some tongue swelling and blistering, which all subsided after 24 hours. The patient still had a lingering sensation but the swelling subsided. Some inner ear itching and her face felt itchy but looked normal. The patient was tired the next day, which could 've been the benedryl and achy here and there. The patient stated no flulike symptoms. Then on Friday at 6:30pm her nose felt hot and her lips swelled up.  Bilateral thighs felt a pulling sensation, upper and lower, and then a bad headache all day yesterday. The outcome of event tongue swelling and blistering was recovered, the others was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Sensory disturbance, Swollen tongue, Tongue blistering
Clinical narrative: some inner ear itching; face felt itchy but looked normal; achy here and there; nose felt hot; lips swelled up; Bilateral thighs felt a pulling sensation, upper and lower; bad headache; tired; had some tongue swelling and blistering/swelling; had some tongue swelling and blistering; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Within 2 hours the patient had some tongue swelling and blistering, which all subsided after 24 hours. The patient still had a lingering sensation but the swelling subsided. Some inner ear itching and her face felt itchy but looked normal. The patient was tired the next day, which could 've been the benedryl and achy here and there. The patient stated no flulike symptoms. Then on Friday at 6:30pm her nose felt hot and her lips swelled up.  Bilateral thighs felt a pulling sensation, upper and lower, and then a bad headache all day yesterday. The outcome of event tongue swelling and blistering was recovered, the others was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: toothache; This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient).  A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 18Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient started with a toothache on 01Apr2021. The patient wanted to know if she can get a tooth extraction before getting her second dose which is due 08Apr2021. The outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, SARS-CoV-2 test
Clinical narrative: came in contact with her grandson a week ago Saturday and Monday. Then on Thursday, her grandson tested positive for Covid; This is a spontaneous report from a contactable consumer (patient herself). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unknown route of administration on 09Mar2021 at single dose for COVID-19 immunization. Medical history and Concomitant medications were not reported. It was reported that patient received the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine on March9 and was scheduled to receive the 2nd dose tomorrow on 06Apr2021. However, she came in contact with her grandson a week ago Saturday and Monday in 2021. Then on Thursday, her grandson tested positive for Covid in 2021. Consumer said she got tested on Friday in 2021, and the results showed negative. she wanted to know if it would be safe for her to receive the 2nd dose. patient also wanted to know how long she should quarantine. patient second dose scheduled more than 21 days. The outcome of event was unknown.  Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthropod bite, Pain in extremity
Clinical narrative: feel asleep on the couch, I had a bug bite that I had scratched and my dog cleaned up the blood; Sore Arm; This is a spontaneous report from a Pfizer sponsored program, received from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2 reported PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 25Mar2021 (Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient mentioned that 10 days (04Apr2021) into her first vaccine shot, she fell asleep on the couch and had a bug bite that she had scratched which her dog cleaned up the blood. The reporter inquired if the dog was at risk from anything from the vaccine. The patient was referred to her Vet since there is no information on effects on dogs. She stated that she had a sore arm for a few days (2021). She added that she had scratched her arm while she was napping and she woke up to her dog licking her arm that was bleeding. She inquired if there will be any harm to the dog by licking her blood from her arm after getting the vaccine 2 weeks ago (also reported as 10 days into her first vaccine shot). The outcome of the events was unknown.  Information related to lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Head injury, Neuralgia, Pain in extremity, Rash
Clinical narrative: arm was sore; bumped her head and got a little bruise on her temple; bumped her head and got a little bruise on her temple; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; This is a spontaneous report received from a contactable consumer (patient). A 68-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced her arm was sore half a day.  About a week later she thought she bumped her head and got a little bruise on her temple and it hadn't gone away. The spot had changed over to a little bit of a rash and it had some neuralgia and peeling. The outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Skin exfoliation
Clinical narrative: arm was sore; bumped her head and got a little bruise on her temple; bumped her head and got a little bruise on her temple; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; This is a spontaneous report received from a contactable consumer (patient). A 68-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced her arm was sore half a day.  About a week later she thought she bumped her head and got a little bruise on her temple and it hadn't gone away. The spot had changed over to a little bit of a rash and it had some neuralgia and peeling. The outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: she got a lot of pain in the arm; This is a spontaneous report from a contactable consumer reported for herself. This female patient with unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 30Mar2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 09Mar2021 for COVID-19 immunisation. After the second dose, she got a lot of pain in the arm and she would like to know what can she use on herself to ease the pain. She had tried with hot water and it helped but the pain hadn't gone. The outcome of event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Upper-airway cough syndrome
Clinical narrative: low grade temperature/fever of 99.7 and it fluctuated to 99.3 and 99.2/99.7F, 100.3F then back to 99.2F; Post nasal drip; This is a spontaneous report received from a contactable consumer reported for herself. A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was scheduled to receive her next dose on 11Apr2021. The patient experienced low grade temperature and post nasal drip on unspecified date. Her low grade fever was continuing. The fever started Saturday morning and this was day 3. On Saturday, she woke up and had a fever of 99.7 and it fluctuated to 99.3 and 99.2.  Lab data included body temperature on unspecified dates: 99.7F, 100.3F then back to 99.2F. The outcome of events was unknown.   No follow-up attempts are possible. Information about batch/lot number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fall
Clinical narrative: dizziness; fall; weakness; This is a spontaneous report from a contactable consumer (patient). An 89-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at single dose for COVID-19 immunization. Medical history included post polio syndrome and myasthenia which compromise immune function. The patient experienced dizziness and weakness which stated as severe side effects of the vaccine. Patient received his first dose of the Pfizer covid vaccine and about 1.5 hours later experienced dizziness which resulted in a fall.  He wanted to know if he should get the second vaccine. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dreamy state, Fatigue, Malaise, Myalgia
Clinical narrative: skin around her ankles and feet are getting discolored; itchy, it is strange; tiredness; muscle pain; chills; fever; injection site hurt a bit; nausea; feeling unwell; dreamy; bad dream; This is a spontaneous report from a contactable consumer (patient) via Medical Information team and Pfizer sponsored program. A 92-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not provided. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 05Mar2021 at single dose for COVID-19 immunization. Patient noticed the skin around her ankles and feet are getting discolored, wanted to know if the vaccine can alter the skin. They are also itchy, it is strange. Her skin around her feet is different than it was. She asked if anyone had reported this or any other skin discoloration or skin symptoms and what she should do about it. Patient stated she certainly experienced tiredness, had muscle pain somewhat, had chills, a small fever, the injection site hurt a bit but it didn't swell, nausea and feeling unwell. She stated she felt like she was being dreamy, not really hallucinations, but like she was having a bad dream. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Nightmare, Pruritus, Pyrexia, Skin discolouration
Clinical narrative: skin around her ankles and feet are getting discolored; itchy, it is strange; tiredness; muscle pain; chills; fever; injection site hurt a bit; nausea; feeling unwell; dreamy; bad dream; This is a spontaneous report from a contactable consumer (patient) via Medical Information team and Pfizer sponsored program. A 92-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not provided. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 05Mar2021 at single dose for COVID-19 immunization. Patient noticed the skin around her ankles and feet are getting discolored, wanted to know if the vaccine can alter the skin. They are also itchy, it is strange. Her skin around her feet is different than it was. She asked if anyone had reported this or any other skin discoloration or skin symptoms and what she should do about it. Patient stated she certainly experienced tiredness, had muscle pain somewhat, had chills, a small fever, the injection site hurt a bit but it didn't swell, nausea and feeling unwell. She stated she felt like she was being dreamy, not really hallucinations, but like she was having a bad dream. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: skin around her ankles and feet are getting discolored; itchy, it is strange; tiredness; muscle pain; chills; fever; injection site hurt a bit; nausea; feeling unwell; dreamy; bad dream; This is a spontaneous report from a contactable consumer (patient) via Medical Information team and Pfizer sponsored program. A 92-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not provided. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 05Mar2021 at single dose for COVID-19 immunization. Patient noticed the skin around her ankles and feet are getting discolored, wanted to know if the vaccine can alter the skin. They are also itchy, it is strange. Her skin around her feet is different than it was. She asked if anyone had reported this or any other skin discoloration or skin symptoms and what she should do about it. Patient stated she certainly experienced tiredness, had muscle pain somewhat, had chills, a small fever, the injection site hurt a bit but it didn't swell, nausea and feeling unwell. She stated she felt like she was being dreamy, not really hallucinations, but like she was having a bad dream. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Feeling hot, Pain in extremity, Rash maculo-papular
Clinical narrative: sore arm that was a little pink, and warm; sore arm that was a little pink, and warm/red arm/was very small spot, slightly raised, sort of pink, and probably the size of a half dollar; small spot, slightly raised, sort of pink, and probably the size of a half dollar; sore arm that was a little pink, and warm; Tired; This is a spontaneous report from a contactable consumer (patient). This 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6203) on 03Mar2021 at single dose for COVID-19 immunization. Medical history included Shellfish Allergy. Concomitant medications were not provided. After receiving first dose, patient had a little bit of a sore arm that was a little pink, and warm. The red arm after first shot, she clarified was very small spot, slightly raised, sort of pink, and probably the size of a half dollar. Patient stated that she was tired for a couple of hours that day, but didn't experience anything big. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: headache; Sore arm where the shot was administered; This is a spontaneous report from a contactable consumer or other non-healthcare professional.  A 42-years-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported) via an unknown route of administration on an unknown date as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient concomitant medications included Colecalciferol, Echinacea. The patient experienced headache and sore arm where the shot was administered. The outcome of the events was unknown.   No follow-up attempts were needed. No further information was expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Pain in extremity, Sputum discoloured
Clinical narrative: headache; Sore arm where the shot was administered; This is a spontaneous report from a contactable consumer or other non-healthcare professional.  A 42-years-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported) via an unknown route of administration on an unknown date as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient concomitant medications included Colecalciferol, Echinacea. The patient experienced headache and sore arm where the shot was administered. The outcome of the events was unknown.   No follow-up attempts were needed. No further information was expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Chills, Hyperhidrosis, Lymph node pain
Clinical narrative: high of 102 degree fever; Sever chills 1-4 am post vaccine; Woke up drenched several times; Muscles felt like she's been shocked with high voltage; Tingling pain in bones and muscles; Tingling pain in bones and muscles; Tingling pain in bones and muscles; Lymph nodes in armpits and legs hurt; Lymph nodes in armpits and legs hurt; Headache approaching migraine; This is a spontaneous report from a contactable consumer (patient) reported that a 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8729), via an unspecified route of administration, administered in arm left on 03Apr2021 16:15 (at the age of 50-years-old) as a single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. The vaccine was administered at the school or student health clinic. The patient medical history included occasional migraine headaches from allergies and hormones from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: En6204), administered in arm left on 13Mar2021 16:15 (at the age of 50-years-old) for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient's concomitant medications were not reported. On 04Apr2021, the patient experienced sever chills 1-4 am post vaccine. High of 102 degree fever 3:00 pm following day (04Apr2021) until falling asleep around 9. On Apr2021, the patient woke up drenched several times. Muscles felt like she's been shocked with high voltage. Tingling pain in bones and muscles. Lymph nodes in armpits and legs hurt. Headache approaching migraine. No treatments were received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Muscle discomfort, Myalgia, Pain in extremity, Paraesthesia
Clinical narrative: high of 102 degree fever; Sever chills 1-4 am post vaccine; Woke up drenched several times; Muscles felt like she's been shocked with high voltage; Tingling pain in bones and muscles; Tingling pain in bones and muscles; Tingling pain in bones and muscles; Lymph nodes in armpits and legs hurt; Lymph nodes in armpits and legs hurt; Headache approaching migraine; This is a spontaneous report from a contactable consumer (patient) reported that a 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8729), via an unspecified route of administration, administered in arm left on 03Apr2021 16:15 (at the age of 50-years-old) as a single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. The vaccine was administered at the school or student health clinic. The patient medical history included occasional migraine headaches from allergies and hormones from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: En6204), administered in arm left on 13Mar2021 16:15 (at the age of 50-years-old) for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient's concomitant medications were not reported. On 04Apr2021, the patient experienced sever chills 1-4 am post vaccine. High of 102 degree fever 3:00 pm following day (04Apr2021) until falling asleep around 9. On Apr2021, the patient woke up drenched several times. Muscles felt like she's been shocked with high voltage. Tingling pain in bones and muscles. Lymph nodes in armpits and legs hurt. Headache approaching migraine. No treatments were received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: high of 102 degree fever; Sever chills 1-4 am post vaccine; Woke up drenched several times; Muscles felt like she's been shocked with high voltage; Tingling pain in bones and muscles; Tingling pain in bones and muscles; Tingling pain in bones and muscles; Lymph nodes in armpits and legs hurt; Lymph nodes in armpits and legs hurt; Headache approaching migraine; This is a spontaneous report from a contactable consumer (patient) reported that a 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8729), via an unspecified route of administration, administered in arm left on 03Apr2021 16:15 (at the age of 50-years-old) as a single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. The vaccine was administered at the school or student health clinic. The patient medical history included occasional migraine headaches from allergies and hormones from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: En6204), administered in arm left on 13Mar2021 16:15 (at the age of 50-years-old) for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient's concomitant medications were not reported. On 04Apr2021, the patient experienced sever chills 1-4 am post vaccine. High of 102 degree fever 3:00 pm following day (04Apr2021) until falling asleep around 9. On Apr2021, the patient woke up drenched several times. Muscles felt like she's been shocked with high voltage. Tingling pain in bones and muscles. Lymph nodes in armpits and legs hurt. Headache approaching migraine. No treatments were received for the events. The outcome of the events was recovering.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: bled to the point that the blood was dripping down the arm; This is a spontaneous report received from a contactable pharmacist. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not provided. The patient administered vaccine over the weekend, had bled to the point that the blood was dripping down the arm. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Tested positive for Covid; Tested positive for Covid; This is a spontaneous report from a non-contactable consumer (patient). A 53-year-old female patient received first dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: unknown) via an unspecified route of administration on 13Mar2021 single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was tested positive for Covid on 29Mar2021. The patient's symptoms were mild, and she was congested and had a headache. The patient had to cancel the appointment for her second dose because she was in quarantine. These events were considered serious (medically significant). The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: continued arm pain after 12 days.  goes from my shoulder down to my forearm.; The is a spontaneous report from contactable consumer.  A consumer (patient) reported for self that the 49-year-old male patient received first dose of bnt162b2 (BNT162B2,  COVID19, Pfizer), via an unspecified route of administration on 24Mar2021 16:00  at single dose for covid-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced "continued arm pain after 12 days.  goes from my shoulder down to my forearm" on 25Mar2021 with outcome of not recovered. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment was received for the adverse event. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No allergies to medications, food, or other products. Reporter wanted to discuss a possible side effect that he is experiencing after he received the firs dose of the vaccine. He did not elaborate further.  No Follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Pruritus, Rash, Urticaria
Clinical narrative: allergic reaction; itchy, raised hives/rashes all over the body; itchy, raised hives/rashes all over the body; itchy, raised hives/rashes all over the body; This is a spontaneous report from contactable male consumer (patient) reported for himself. A 42 years old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6199) via unspecified route of administration in left arm on 01Apr2021 10:45 AM at age of 42 years old at single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications the patient received within 2 weeks of vaccination was unknown. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. Patient previous received the first dose of BNT162B2 (Pfizer/BioNTech COVID-19 vaccine, Lot number EL3248) on 09Mar2021 02:00 PM at age of 42 years old at single dose in left arm for COVID-19 immunisation. Patient developed itchy, raised hives/rashes all over the body, after 48 hrs (on April 3rd evening) of receiving the 2nd dose of the vaccine. Contacted the Teledoc and got prescription for diphenhydramine hydrochloride (BENADRYL). Patient stated he was the patient who experience the adverse event and he developed the allergic reaction on 3rd April 2021 (48 hrs after receiving 2nd dose). So his aware date was 3rd April 2021 (around 4 pm). The adverse event result in Doctor or other healthcare professional office/clinic visit. After taking 4 doses (36 hrs) all the hives/rashes disappeared. Outcome of events was recovered.   No follow up attempt needed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: positive for Covid; positive for Covid; This is a spontaneous report from a contactable consumer (patient). This consumer reported same events for two patients. This is the first of two reports. A 55-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 16Mar2021 as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that both patient and his wife got their first Pfizer covid vaccine on 16Mar2021. They had not been feeling well for two weeks and on 31Mar2021, they both tested positive for Covid. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021374570 same reporter/ drug/ event, different patient
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: got the first dose; however they have tested positive for COVID 19 Virus; got the first dose; however they have tested positive for COVID 19 Virus; This is a spontaneous report from a Pfizer Sponsored Program. A contactable 55-year-old male consumer (patient) received first dose of BNT162B2 (Solution for injection, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration on 16Mar2021 (at the age of 55-year-old) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 01Apr2021, the patient was tested positive for COVID-19 after first dose of vaccine. Patient questioned whether he can take the 2nd vaccine dose as schedule or should he reschedule it. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 01Apr2021. The outcome of events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021400518 same reporter/drug/event, different patient
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: positive for Covid; positive for Covid; This is a spontaneous report from a contactable consumer. This consumer reported same events for two patients. This is the second of two reports. A 56-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 16Mar2021 as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that both patient and her husband got their first Pfizer Covid vaccine on 16Mar2021. They had not been feeling well for two weeks and on 31Mar2021, they both tested positive for Covid. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021372942 same reporter/ drug/ event, different patient
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Influenza like illness, Lacrimation increased
Clinical narrative: flu like symptoms; congestion in her nose; a low grade fever of 99.3; cold and flu like symptoms; eyes very watery; chill; throat is itchy; just a little tired; shoulder was sore; This is a spontaneous report received from a contactable consumer(Patient). This consumer (patient) reported for herself that the 54-year-old female patient received first dose of bnt162b2 (BNT162B2, Pfizer- Biontech COVID-19 Vaccine, Batch/lot number : ER8722 or 8732) via an unspecified route of administration, administered in Arm Left on 27Mar2021 at single dose for covid-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing (knee surgery), pain from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing (sometimes she has allergy symptoms). Concomitant medication(s) included paracetamol (TYLENOL) taken for arthritis, start and stop date were not reported; vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported; fish oil, oenothera biennis oil, tocopheryl acetate (OMEGA 3 & 6) taken for an unspecified indication, start and stop date were not reported; glucosamine sulfate (COSAMINE [GLUCOSAMINE SULFATE]) taken for an unspecified indication, start and stop date were not reported. The patient experienced shoulder was sore on 27Mar2021 with outcome of recovered on 30Mar2021, just a little tired on 28Mar2021 with outcome of recovered on 30Mar2021, nose is full on 05Apr2021 with outcome of not recovered, cold like symptoms on an unspecified date with outcome of unknown , congestion in her nose (nose is full and eyes very watery) on 05Apr2021 with outcome of not recovered, a low grade fever of 99.3 (fever, not high, 99.3) on 05Apr2021 with outcome of not recovered, throat is itchy on 03Apr2021 with outcome of not recovered, chill on 04Apr2021 with outcome of not recovered, eyes very watery on 05Apr2021 with outcome of not recovered. The patient underwent lab tests and procedures which included pyrexia: 99.3 on 05Apr2021.   The clinical course was reported as follows: "Caller received the first dose of the Covid vaccine on March 27th. Caller reports doing well only having a sore shoulder and was tired for a few days. Caller states a week later, she started experiencing cold and flu like symptoms that consisted of a sore throat, congestion in her nose, a low grade fever of 99.3. Caller asked if this is side effects of the vaccine? Can I experience side effects a week later? Caller asked if she does get better, should she keep her original appointment or schedule for a later date?"     No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nasopharyngitis, Pyrexia, Throat irritation
Clinical narrative: flu like symptoms; congestion in her nose; a low grade fever of 99.3; cold and flu like symptoms; eyes very watery; chill; throat is itchy; just a little tired; shoulder was sore; This is a spontaneous report received from a contactable consumer(Patient). This consumer (patient) reported for herself that the 54-year-old female patient received first dose of bnt162b2 (BNT162B2, Pfizer- Biontech COVID-19 Vaccine, Batch/lot number : ER8722 or 8732) via an unspecified route of administration, administered in Arm Left on 27Mar2021 at single dose for covid-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing (knee surgery), pain from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing (sometimes she has allergy symptoms). Concomitant medication(s) included paracetamol (TYLENOL) taken for arthritis, start and stop date were not reported; vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported; fish oil, oenothera biennis oil, tocopheryl acetate (OMEGA 3 & 6) taken for an unspecified indication, start and stop date were not reported; glucosamine sulfate (COSAMINE [GLUCOSAMINE SULFATE]) taken for an unspecified indication, start and stop date were not reported. The patient experienced shoulder was sore on 27Mar2021 with outcome of recovered on 30Mar2021, just a little tired on 28Mar2021 with outcome of recovered on 30Mar2021, nose is full on 05Apr2021 with outcome of not recovered, cold like symptoms on an unspecified date with outcome of unknown , congestion in her nose (nose is full and eyes very watery) on 05Apr2021 with outcome of not recovered, a low grade fever of 99.3 (fever, not high, 99.3) on 05Apr2021 with outcome of not recovered, throat is itchy on 03Apr2021 with outcome of not recovered, chill on 04Apr2021 with outcome of not recovered, eyes very watery on 05Apr2021 with outcome of not recovered. The patient underwent lab tests and procedures which included pyrexia: 99.3 on 05Apr2021.   The clinical course was reported as follows: "Caller received the first dose of the Covid vaccine on March 27th. Caller reports doing well only having a sore shoulder and was tired for a few days. Caller states a week later, she started experiencing cold and flu like symptoms that consisted of a sore throat, congestion in her nose, a low grade fever of 99.3. Caller asked if this is side effects of the vaccine? Can I experience side effects a week later? Caller asked if she does get better, should she keep her original appointment or schedule for a later date?"     No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Covid arm; Covid arm; This is a spontaneous report received from a contactable consumer (reporting on herself). A 76-years-old Non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: solution for injection; lot number: EN6200 and Expiry Date was not reported) via an unspecified route of administration in Arm Left on Feb2021 06:30 (at the age of 76-years-old) as a single dose for COVID-19 immunization. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. It was reported that on Mar2021 at 08:00, patient experienced COVID arm. No treatment was received for adverse event. Since the vaccination, patient was not tested for COVID-19.  Follow-up attempts are needed, further information is expected.